OUR MISSION

Revolutionizing the Approach to Spine Surgery

ATEC is more than a medical technology company. We are an Organic Innovation Machine™ that is focused on Revolutionizing the Approach to Spine Surgery. We are committed to creating clinical distinction by developing new approaches to treat the various pathologies to ultimately achieve the goals of spine surgery. Our ultimate vision is to become The Standard-Bearer in Spine.

stand·ard-bear·er

/ˈstandərd ˌberər/

  • A leading figure in a cause or movement.

ATEC is committed to delivering improved patient care, and our strengths are derived through our ability to embody our Core Values.

Mission

Revolutionizing the Approach to Spine Surgery

Vision

The Standard-Bearer in Spine

Values

- Deliver high performance

- Demonstrate GRIT

- Be constantly curious

- Commit to clinical distinction

- Be gracious, familial, & inspire others

- Love what you do

- #ATECPROUD

Dr. Pimenta

Profound Curiosity

ATEC is focused on developing new standards for spine surgery regardless of surgical approach. With so much variation in spine surgery today, there is a great opportunity for ATEC to deliver new approaches that achieve the goals of surgery –decompression, stabilization, and alignment.

 

Luiz Pimenta MD, PhD
Chief Medical Officer

A Message from Our CEO

Leadership

Executive Team

Pat Miles

Patrick S. Miles

Chairman and Chief Executive Officer

 

PATRICK S. MILES


Chairman and Chief Executive Officer

Patrick S. Miles has served as Chairman and Chief Executive Officer of Alphatec Holdings and Alphatec Spine since October 2017. Mr. Miles has over 20 years of experience in the orthopaedic industry and most recently served, from September 2016 to September 2017, as the Vice Chairman of NuVasive. As Vice Chairman, Mr. Miles was responsible for enhancing the Company’s strategic plans for the future of spine surgery and supporting technology development. Mr. Miles served as a member of NuVasive’s Board of Directors since August 2016 until his resignation in September 2017. Prior to that, Mr. Miles served as NuVasive’s President and Chief Operating Officer from February 2015 to September 2016. He previously served as NuVasive’s President of Global Products and Services from October 2011 to January 2015, President of the Americas from January 2010 to September 2011, Executive Vice President of Product Marketing and Development from January 2007 to December 2009, Senior Vice President of Marketing from December 2004 to January 2007, and as its Vice President, Marketing from January 2001 to December 2004. Prior to those positions, he served as Director of Marketing for ORATEC Interventions, Inc., a medical device company, and as a Director of Marketing for Minimally Invasive Systems and Cervical Spine Systems for Medtronic Sofamor Danek, and held several positions with Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.

Craig Hunsacker

Craig Hunsaker

Executive Vice President, People & Culture and General Counsel

CRAIG HUNSAKER


Executive Vice President, People & Culture and General Counsel

Craig Hunsaker has served as Executive Vice President, People & Culture since September 2016, and as General Counsel since March 2017.  In these roles, he is responsible for all aspects of employee recruitment, development, engagement and corporate culture, and is the Company’s chief legal officer and Corporate Secretary. Craig's professional career includes 16 years practicing law at some of the world's largest technology focused law firms, advising and defending companies and management with respect to their people and trade secrets decisions, while holding various leadership positions. Craig left full-time legal practice in 2009, when he joined NuVasive, Inc., a publicly traded spinal implant company, first to serve as Vice President, Legal Affairs, then as Senior Vice President, Global Human Resources until March 2014.  From April 2014 until he joined Alphatec Spine, Craig owned a consulting business, assisting employers in the areas of Employment Law and Human Resources, including as Senior Advisor, Human Resources at General Atomics, a San Diego-based defense contractor. Craig received his J.D. from Columbia University School of Law, where he was a Harlan Fiske Stone Scholar, and his B.S. in International Business & Finance from Brigham Young University.

Jeff Black

Jeff Black

Executive Vice President and Chief Financial Officer

 

JEFF BLACK


Executive Vice President and Chief Financial Officer

Jeff Black has served as Executive Vice President and Chief Financial Officer since March 2017. He brings more than 25 years’ experience in financial and operations management to Alphatec Spine. Jeff was previously the CFO at Applied Proteomics, a non-invasive diagnostics company. In the past, he served as CFO at AltheaDx and Verenium Corporation (formerly Diversa Corporation). Over the course of his professional career, he has been in financial leadership roles while raising more than $500 million in strategic equity, and debt-financing transactions. Jeff started his career at Ernst & Young LLP and received a B.S. of Business Administration from the University of Arizona.

Brian Snider

Brian Snider

Executive Vice President, Marketing and Development

BRIAN SNIDER


Executive Vice President, Marketing and Development

Brian Snider has served as Executive Vice President, Marketing and Development since March 2017.  Prior to joining Alphatec Spine, Brian held various marketing leadership and global product management roles within NuVasive, Inc. from 2008 to 2017.  He most recently served as the Business Lead of Thoracolumbar Anterior, which included overall responsibility for the anterior column business including XLIF®.  Prior to NuVasive, Brian held marketing leadership roles for Alveolus, Inc., a medical device company focused on interventional stent technologies.  He started his career at KPMG Consulting in various business units including Life Sciences.  Brian received an MBA from the Fuqua School of Business at Duke University and a BBA in Marketing and Information Systems from The George Washington University.

Mark Ojeda

Mark D. Ojeda

Executive Vice President, Cervical & Biologics

 

MARK D. OJEDA


Executive Vice President, Cervical & Biologics

Mark D. Ojeda has served as Executive Vice President, Cervical and Biologics since September 2018. Prior to joining Alphatec Spine, Mark held several leadership positions at Nuvasive, Inc from 2006 to 2017.  Most recently, Mark led Cervicothoracic Systems where he reported to the President/COO. Prior to that, Mark was Director of Regional Marketing, Adult Hip Reconstructive Systems at Smith & Nephew Orthopedics, Inc. Mark completed an M.B.A. in Marketing and Finance at Christian Brothers University in Memphis, Tennessee, and a B.S. in Packaging Science, Technical Option at Michigan State University, East Lansing, Michigan.

Eric Dasso

Eric Dasso

Executive Vice President, Adjunctive Technologies

 

ERIC DASSO


Executive Vice President, Adjunctive Technologies

Eric Dasso has served as Executive Vice President, Adjunctive Technologies since August 2019.  Prior to joining the Company, Mr. Dasso held various marketing leadership and global product management roles within NuVasive, Inc. from 2001 to 2018.  He most recently served as NuVasive’s Vice President, Global Implant Systems (February 2015 to June 2018), which included overall responsibility for that company’s product development, commercialization and marketing functions of its $750M global implant franchise.  Prior to leading Global Implant Systems, Mr. Dasso over saw the marketing and development of NuVasive’s thoracolumbar portfolio in various roles of increasing responsibility from February 2005 to February 2015, including as Project Manager, Thoracolumbar Fixation (February 2005 to July 2007), Senior Project Manager, Thoracolumbar Fixation (July 2007 to September 2008), Director, Marketing, Thoracolumbar Fixation (September 2008 to June 2010), Senior Director, Thoracolumbar (June 2010 to January 2014) and as Vice President, Thoracolumbar Posterior (January 2014 to February 2015).  Prior to Nuvasive, Mr. Dasso held various positions at Johnson and Johnson and Acxiom Inc.  Mr. Dasso received a bachelor’s degree in Business Administration from California Polytechnic State University—San Luis Obispo.

Kelli Howell

Kelli Howell

Executive Vice President, Clinical Strategies

 

KELLI HOWELL


Executive Vice President, Clinical Strategies

Kelli Howell has served as Executive Vice President, Clinical Strategies since March 2018. For the 18 years prior to joining us, she held various management positions at NuVasive, Inc., including Vice President, Research & Health Informatics from January 2017 to March 2018, Vice President, Research & Education of NuVasive, Inc. from February 2015 to January 2017, and Vice President, Research at NuVasive, Inc. from April 2012 to February 2015. Prior to joining NuVasive, Inc., Ms. Howell was involved in research at Orthopedic Biomechanics Laboratory (OBL), Beth Israel Deaconess Medical Center in Boston. Ms. Howell received a M.S. degree in Biomedical Engineering from Boston University and a B.A. degree in Engineering Sciences from Dartmouth College.

David Sponsel

Dave Sponsel

Executive Vice President, Sales

 

DAVE SPONSEL


Executive Vice President, Sales

Dave Sponsel has served as Executive Vice President, Sales since April 2019. Dave began his career at Alphatec Spine as Area Vice President, Sales, South in May 2018. Prior to joining Alphatec Spine, he held the position of General Manager, Spine Division for Medacta, USA, where he was responsible for sales, marketing, product management and product development. Prior to that, he had an exceedingly successful 11-year experience in sales and sales leadership with Stryker Spine, where he was recognized as Sales Director of the Year in 2014. Dave received a BS from Indiana State University in Business Management.

Board of Directors

The Board of Directors has direct access to independent experts – lawyers, accountants and compensation experts – to turn to for counsel regarding specific company polices and activities.

The Audit Committee of the Board of Directors pre-approves all audit and permitted non-audited services, and reviews quarterly and year-end financial statements and associated press releases with our financial management and outside, independent auditors in advance of the filing or release of such documents.

The Compensation Committee of the Board of Directors approves all compensation-related matters involving Alphatec Spine’s senior management. In addition, The Compensation Committee of the Board of Directors approves all bonus plans and acts as the administrator of the company’s stock option plan and employee stock purchase plan.

Pat Miles

Patrick S. Miles

Chairman and Chief Executive Officer

 

 

PATRICK S. MILES


Chairman and Chief Executive Officer

Patrick S. Miles has served as Chairman and Chief Executive Officer of Alphatec Holdings and Alphatec Spine since October 2017. Mr. Miles has over 20 years of experience in the orthopaedic industry and most recently served, from September 2016 to September 2017, as the Vice Chairman of NuVasive. As Vice Chairman, Mr. Miles was responsible for enhancing the Company’s strategic plans for the future of spine surgery and supporting technology development. Mr. Miles served as a member of NuVasive’s Board of Directors since August 2016 until his resignation in September 2017. Prior to that, Mr. Miles served as NuVasive’s President and Chief Operating Officer from February 2015 to September 2016. He previously served as NuVasive’s President of Global Products and Services from October 2011 to January 2015, President of the Americas from January 2010 to September 2011, Executive Vice President of Product Marketing and Development from January 2007 to December 2009, Senior Vice President of Marketing from December 2004 to January 2007, and as its Vice President, Marketing from January 2001 to December 2004. Prior to those positions, he served as Director of Marketing for ORATEC Interventions, Inc., a medical device company, and as a Director of Marketing for Minimally Invasive Systems and Cervical Spine Systems for Medtronic Sofamor Danek, and held several positions with Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.

Mortimer Berkowitz III

Mortimer Berkowitz III

Lead Director, Chairman of the Nominating and Corporate Governance Committee

 

MORTIMER BERKOWITZ III


Lead Director, Chairman of the Nominating and Corporate Governance Committee

Mortimer Berkowitz III is the Lead Director and has served as a member of the Board of Directors since March 2005. From April 2007 through July 2011, he also served as the Chairman of the Board of Directors. He is currently President and CEO of InnovaHealth Partners, L.P. He is also a managing member of HGP, LLC, which is the general partner of HealthpointCapital Partners, LP, President, and a managing director of HealthpointCapital, LLC. He has held the position with HGP, LLC since its formation in August 2002, as well as the positions of managing director and member of the Board of Managers of HealthpointCapital, LLC since its formation in July 2002 and the position of President of HealthpointCapital, LLC since February 2005. Prior to joining HealthpointCapital, LLC, Mr. Berkowitz was managing director and co-founder of BPI Capital Partners, LLC, a private equity firm founded in 1990. Prior to 1990, Mr. Berkowitz spent 11 years in the investment banking industry with Goldman, Sachs & Co., Lehman Brothers Incorporated and Merrill Lynch & Co. Mr. Berkowitz serves on the Leadership Council of the Harvard School of Public Health.

Don Williams

Donald A. Williams

Director, Chairman of the Audit Committee and Member of the Finance Committee

 

DONALD A. WILLIAMS


Director, Chairman of the Audit Committee

Donald Williams has served as a member of the Board of Directors since April 2015. Mr. Williams is a 35-year veteran of the public accounting industry, retiring in 2014. Mr. Williams spent 18 years as an Ernst & Young partner and the last seven years as a Partner with Grant Thornton. During the last seven years at Grant Thornton, he served as the national leader of Grant Thornton’s life sciences practice and the managing partner of the San Diego Office. Mr. Williams also has serves as a director of Akari Therapeutics Plc, ImpediMed Ltd and is on the Board of Advisors of the Southern Illinois University School of Accountancy.

Dave Mowry

David H. Mowry

Director, Member of the Audit and Finance Committees

 

DAVID H. MOWRY


Director, Member of the Audit Committee

David H. Mowry has served as a member of the Board of Directors since February 2017.  Mr. Mowry currently serves as the Chief Executive Officer of Cutera, Inc., a leading provider of energy-based aesthetic systems for physicians and other qualified practitioners worldwide. Prior to joining Cutera in July 2019, Mr. Mowry served as President, Chief Executive Officer and a director of Vyaire Medical, a recognized global leader in the respiratory diagnostics, ventilation, and anesthesia delivery and patient monitoring market segments, a position he held since May 2016.  From October 2015 to May 2016 he served as Executive Vice President and Chief Operating Officer and member of the board of directors of Wright Medical Group N.V. (Nasdaq: WMGI), a global medical device company focused on extremities and biologics products, and during this time period he was also a member of the board of directors of EndoChoice Holdings, Inc. , a company focused on the manufacturing and commercialization of platform technologies relating to the treatment of gastrointestinal conditions. Prior to Wright Medical Group, Mr. Mowry served as President and Chief Executive Officer and member of the board of directors of Tornier N.V. from February 2013 until October 2015, at which time Tornier and Wright Medical Group merged, and prior to that, as Chief Operating Officer of Tornier from 2011 to 2013. Prior to this, Mr. Mowry held executive leadership positions at Covidien plc, ev3, Inc. and Zimmer Spine, Inc.  Mr. Mowry received a B.S. in Engineering from the United States Military Academy at West Point.

Jeff Rydin

Jeffrey P. Rydin

Director

 

 

JEFFREY P. RYDIN


Director, Member of the Nominating and Governance Committee

Jeffrey P. Rydin has served as a director since June 2017 and as a Special Advisor to the Board since September 2016.  Mr. Rydin has spent more than 27 years in the medical device and healthcare industries. Prior to joining Alphatec as Special Advisor to the Board, Mr. Rydin served as Chief Sales Officer of Ellipse Technologies, Inc., a medical technology company, from September 2015 until its purchase by NuVasive, Inc. in February 2016. Before joining Ellipse, Mr. Rydin served as President of Global Sales at NuVasive (October 2011 to March 2013), where he was responsible for NuVasive’s worldwide sales efforts, including the oversight of strategic sales development, sales administration, Area Vice Presidents and sales training. Prior to his position of President of Global Sales, he served as Executive Vice President of Sales—Americas and Senior Vice President, U.S. Sales since joining NuVasive in December 2005. Prior to joining NuVasive, Mr. Rydin served as Area Vice President, Sales (US Southeast region) at DePuy Spine, Inc. from January 2003 to December 2005. Mr. Rydin also served as Vice President of Sales at Orquest, Inc. from December 2001 to January 2003, Director of Sales at Symphonix Devices, Inc. from April 2000 to December 2001 and Director of Sales at General Surgical Innovations, Inc. from October 1996 to March 2000. Mr. Rydin also has served in various executive and leadership sales roles at General Surgical Innovations, Baxter Healthcare, US Surgical Corporation and Xerox. He currently serves as director of DuraStat, LLC. Mr. Rydin received a B.A. degree in Social Ecology from the University of California, Irvine.

Quentin Blackford

Quentin Blackford

Director, Chairman of the Finance Committee, and Member of the Audit and Compensation Committees

QUENTIN BLACKFORD


Director, Chairman of the Finance Committee and Member of the Audit and Compensation Committees

Quentin Blackford has served as a Director of Alphatec Holdings and Alphatec Spine since October 2017. Mr. Blackford currently serves as the Chief Financial Officer of DexCom, Inc., a company focused on developing and marketing continuous glucose monitoring systems for ambulatory use by people with diabetes and by healthcare providers. Prior to joining DexCom in August 2017, Mr. Blackford served since August 2016 as the Executive Vice President, Chief Financial Officer, Head of Strategy and Corporate Integrity of NuVasive, Inc., a medical device company focused on developing minimally disruptive surgical products and procedures for the spine. In this role, Mr. Blackford was responsible for leading NuVasive’s Finance, Strategy and Corporate Development, Compliance and Regulatory functions. From August 2014 until August 2016, Mr. Blackford served as NuVasive’s Executive Vice President, Chief Financial Officer. From July 2012 to August 2014, Mr. Blackford served as NuVasive’s Executive Vice President of Finance and Investor Relations, and from January 2011 to June 2012, he served as NuVasive’s Vice President, Finance. Mr. Blackford joined NuVasive in 2009 as its Corporate Controller and was previously employed at Zimmer Holdings, Inc., including most recently as the Director of Finance and Controller for Zimmer’s Dental Division. He obtained his Certified Public Accounting license (currently inactive) following the achievement of dual Bachelor of Science degrees in Accounting and Business Administration, with an emphasis in Accounting, from Grace College.

Ward Woods

Ward W. Woods

Director, Chairman of the Compensation Committee

 

WARD W. WOODS


Director, Chairman of the Compensation Committee

Ward W. Woods currently serves as Chairman of the Advisory Board of the Stanford Woods Institute, as Chair Emeritus and trustee of the Wildlife Conservation Society and as a trustee of the David & Lucille Packard Foundation. He is a member of the Council on Foreign Relations. He is former President and Chief Executive Officer of Bessemer Securities Corporation and Founding Partner of Bessemer Holdings, L.P. (1989-2003), a private equity firm. From 1978 to 1989, Mr. Woods was a senior partner and member of the Management Committee of Lazard Freres & Company. Prior to joining Lazard, Mr. Woods was a Managing Director and a Partner of Lehman Brothers and was co-head of the Corporate Finance Department. He joined Lehman Brothers in 1967 and was elected partner in 1973. Upon graduation from Stanford University in 1964, Mr. Woods joined the Fay Improvement Company, an engineering construction and real estate firm in San Francisco and in 1966 became its general manager, acting in that capacity until the company was sold in 1967. He is a former Trustee of Stanford University, former Chairman of The Stanford Management Company and a former trustee of the National Fish and Wildlife Foundation. Mr. Woods has also served as former Governor and Treasurer of The Nature Conservancy, Vice-Chair and trustee of The Asia Society and a trustee of The Boys Club of New York.

Evan Bakst

Evan Bakst

Director

 

 

EVAN BAKST


Director

Evan Bakst has served as a Director since March 2018. Mr. Bakst is the Founder and Portfolio Manager of Treetop Capital since 2013, a fundamental, value-oriented investment firm focused primarily on small to midcap healthcare companies. Before launching Treetop, Mr. Bakst spent seven years (2005-2012) at Tremblant Capital, a long/short equity hedge fund, most recently as a Partner where he led the healthcare group. Prior to joining Tremblant, Mr. Bakst was a Principal at JPMorgan Partners, LLC (2000-2005), where he shared the day-to-day responsibility for managing the healthcare buyout practice. Previously, Mr. Bakst was a Managing Director at The Beacon Group, a private equity/M&A boutique and, prior to that, Mr. Bakst worked as a Consultant at Bain and Company, providing strategic and operational advice to a major healthcare company. Mr. Bakst is currently on the Board of Sonacare Medical, LLC, and was formerly on the Boards of Accordant Health Services, Cadent Holdings, Inc., FundsXpress Inc., Iasis Healthcare, MedQuest Associates, National Surgical Care, Quality Tubing Inc. and ValueOptions. Mr. Bakst earned a B.A. in Economics from the University of California, Berkeley, and an M.B.A. from the Harvard Business School.

Jason Hochberg

Jason Hochberg

Director

 
 
 

JASON HOCHBERG


Director

Jason Hochberg has served as a Director since March 2018. Mr. Hochberg is a partner with L-5 Healthcare Partners, and founded SJS Beacon in 2013, an investment company focused on real estate and private equity investments. From 1999 until 2013, Mr. Hochberg was employed at LS Power, an energy development and investment company, serving most recently as its Chief Operating Officer. During his tenure at LS Power, he also served as General Counsel of LS Power and as a principal in LS Power’s private equity group which managed over $3 billion in equity capital. He started his professional career at the law firm of Latham & Watkins in 1996 as an associate. Mr. Hochberg has a B.A from SUNY Albany, a J.D., magna cum laude, from Yeshiva University, Benjamin Cardozo Law School and a M.B.A in finance from NYU, the Stern School of Business.

Jim Tullis

James L.L. Tullis

Director, Member of the Nominating and Corporate Governance Committee

 

JAMES L.L. TULLIS


Director, Member of the Nominating and Corporate Governance Committee

James L.L. Tullis has served as a Director since March 2018. With a career of over 40 years in healthcare investing, he currently serves as the Chairman at Tullis Health Investors, a position he has held since 1985. Prior to founding Tullis Health Investors, Mr. Tullis was senior vice president of E.F. Hutton &Co. and a principal at Morgan Stanley & Co. where he led healthcare investment research and, later, healthcare investment banking. During his tenure at Morgan Stanley, he received recognition 14 times on the Institutional Investor All-Star list of Wall Street’s top securities analysts and was twice named #1 Drug Analyst and was featured on the Wall Street Week television program. He also serves as a Director of Lord Abbett family of mutual funds; Crane Corporation; electroCore, LLC; Exagen Diagnostics, Inc.; LivHOME, Inc.; and SupplyPro, Inc.. Mr. Tullis earned an M.B.A. from Harvard Business School and BA from Stanford University.

Karen McGinnis

Karen McGinnis

Director, Member of the Compensation and Finance Committees

 

KAREN MCGINNIS


Director, Member of the Compensation Committee

Ms. McGinnis has served as a member of the Board of Directors since June 2019. Ms. McGinnis has over 20 years of experience in executive operational and finance roles at international public and private companies. She currently serves as the Chief Accounting Officer of Illumina, Inc., a leader in sequencing- and array-based solutions for genetic and genomic analysis. Prior to joining Illumina in November 2017, Ms. McGinnis served from February 2016 to April 2017 as Director, President and Chief Executive Officer of Mad Catz Interactive, Inc. a global provider of innovative interactive entertainment products. From June 2013 through February 2016, Ms. McGinnis served as Mad Catz’ Chief Financial Officer. Prior to joining Mad Catz, Ms. McGinnis served from November 2009 through May 2013 as Chief Accounting Officer of Cymer, Inc., the world’s leading supplier of light sources used in the photolithography process for semiconductor or chip manufacturing until its acquisition in 2013. Ms. McGinnis also served as Chief Accounting Officer for Insight Enterprises, Inc., from September 2006 until March 2009, its Senior Vice President of Finance from 2001 through September 2006 and its Vice President of Finance from 2000 through 2001. She also served as Chief Financial Officer and Treasurer of Horizon from 1997 through 2000 and worked for the assurance practice of KPMG LLP from 1989 through 1997, most recently as a Senior Manager. McGinnis is a Certified Public Accountant and earned her Bachelor’s Degree in Accounting from the University of Oklahoma.

David_Pelizzon

David Pelizzon

Director

 
 
 

David Pelizzon


Director

David Pelizzon has served as a member of the Board of Directors since June 2020.  Mr. Pelizzon currently (and since 2008) serves as President and member of the Managing Committee of Squadron Capital, an investment firm that primarily manages direct investments in operating companies, private equity funds and special situations. He also currently serves (since 2011) as a member of the Board of Directors of OrthoPediatrics, a company exclusively focused on advancing the field of pediatric orthopedics. From 2005 to 2008, Mr. Pelizzon served as the Managing Director of Precision Edge Holdings, a subsidiary of Colson Associates. Mr. Pelizzon is a retired U.S. Army officer who served nearly 30 years on active duty in airborne and special operations units. Mr. Pelizzon is a graduate of the U.S. Military Academy and earned advanced degrees from Harvard University and the U.S. Naval War College.

Contact Us

CORPORATE HEADQUARTERS

Alphatec Spine, Inc.
5818 El Camino Real
Carlsbad, CA 92008

P: +1-760-431-9286
P: +1-800-922-1356

Hours of Operation:
Mon-Fri 7:00am-5:30pm PST

SALES AND CUSTOMER SERVICE

P: +1-800-922-1356 [Tollfree]
P: +1-760-431-9286
F:  +1-800-431-9722

Hours of Operation:
Mon-Fri 6am - 5:30pm PST

PEOPLE AND CULTURE

P: +1-760-431-9286
F: +1-760-494-6937

INVESTOR RELATIONS

Josh Berg
Berg Capital Markets
P: (760) 494-6790

Have a question?